InvestorsHub Logo
Followers 58
Posts 9972
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Saturday, 10/19/2019 10:01:30 AM

Saturday, October 19, 2019 10:01:30 AM

Post# of 455242
Oldie .. .but still a goodie...from , Cells
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468724/

Check out the ref to A2-73 … Autophagy and numerous supporting points. No contradictions noted vs numerous historical Amyloid thesis stories which were just ignored as anecdotes. Sound practice shows that each and every thesis contradiction must be carefully evaluated, which of course BP never seriously did. Decades were lost b/c money and systemic influences wanted it that way. Any legitimate organization would have conducted an after action panel and vigorously reviewed what they did wrong. As far as I know that never happened. Consequently the Rest of the World (ROW) is left to "go figure it out...for your selves". Which of course is exactly what we (AVXL-TGA, EU..._others ) are in the process of doing. We note that the investment system (WS) have not yet figured this out as they wait to game who ever looks to be making progress. This is just the opposite from how they system is intended to work. I would like to see some kind of serious investigation taken (WW) as to why we cannot rely on the established investment-financial system to minimally mange itself w/some sense of integrity. With luck, that day will come. Not only do we need an effective medical process for treatment development but we also need some sense of integrity in the system. Much bigger issue.

Bottom line: The answer is right here (See cells piece) in front of us, soon to be iterated by peer reviewed process (if it works as it should). An awful lot on the table. IMO, this little company's trial results bring more than just the treatment facts. We bring-drive the need for an entirely new system also.

Solving for results/ over time remain the issue for many of us.(note this is how many define productivity) We collectively agree this is a correct path. Will we see it in our lifetimes is the question??? I think yes, but it is unclear to me just how the ROW will understand-read the answers and then what. Privately, IMO, CNS cellular Homeostasis (degenerative-regenerative impact) applies in a vast majority of CNS diseases, WW. AVXL is about to (w/in months) completely rewrite the medical books. Stand by... this is NOT A DRILL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News